Sinapsos Podcast | Oncology

E54   |  8 min   |   Latest   |  Publication Link

• Podcast based on: Shrivastava, T.; Medik, Y.; Kumar, N.S.; Tu, S.; Kunthur, A. Prognosis and Therapies in Non-Clear Cell Renal Cell Carcinomas. Cancers 2026, 18, 3224. https://doi.org/10.3390/cancers18193224
  Type: Review  |  Publication date: 07 October 2026
  
  
• Summary: Non-clear cell renal cell carcinomas (nccRCCs) comprise a heterogeneous group of kidney cancers with distinct biological features and clinical outcomes. Prognosis varies substantially according to histology and molecular drivers. Historically, outcomes have been inferior to those of clear cell RCC because subtype-specific evidence has been limited. Immune checkpoint inhibitors, targeted agents, and combination strategies have improved response rates, but optimal management remains uncertain. Progress will depend on molecular stratification, subtype-specific trials, and integration of genomic and epigenomic insights to individualize prognosis and therapy.
  
  
• Keywords: non-clear cell renal cell carcinoma; papillary renal cell carcinoma; chromophobe renal cell carcinoma; immune checkpoint inhibitors; molecular biomarkers; prognosis; systemic therapy

License and disclaimer:
Original article © 2026 by the authors. Licensed under the Creative Commons Attribution 4.0 (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/). This episode is an AI-generated audio adaptation of the article: the script and the voices are synthetic, changes were made, and the adaptation is not endorsed by the authors, the journal, or the publisher. It may contain errors or omissions, so consult the original publication before relying on any detail. It is for educational purposes only and is not medical advice. The creators accept no liability for any use of this content.